About ONCOSTING LLC
OncoSTING is a biotechnology company focused on developing novel bladder cancer therapies using STING agonists delivered via BCG. The company was founded in 2026 and is led by a team of experts in urology, oncology, and infectious diseases.
Development of bladder cancer therapiesUtilization of STING agonistsDelivery of therapies via BCG
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ONCOSTING LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.